SCHEMBL14440896

SCHEMBL14440896

CCCCCCCCCCC/C=C\CCCCC(=O)Nc1cc(C(=O)O)ccc1Oc1cc(C(=O)O)cc(C(=O)O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 2/20 0.58
SOAT2 O75908 1/20 0.51
SOAT1 P35610 1/20 0.51
CNR1 P21554 6/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
GAA P10253 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
POLB P06746 1/20 0.47
ATM Q13315 1/20 0.47
PSMB11 A5LHX3 1/20 0.47
PSMA7 O14818 1/20 0.47
PSMB1 P20618 1/20 0.47
PSMA1 P25786 1/20 0.47
PSMA2 P25787 1/20 0.47
PSMA3 P25788 1/20 0.47
PSMA4 P25789 1/20 0.47
PSMB8 P28062 1/20 0.47
PSMB9 P28065 1/20 0.47
PSMA5 P28066 1/20 0.47
PSMB4 P28070 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14429901 0.94 S1PR3 (0.64) S1PR3SOAT1L3MBTL1GAATDP1
SCHEMBL14429926 0.88 PSMB11 (0.52) S1PR3SOAT2SOAT1CNR1L3MBTL1
SCHEMBL9502168 0.87 GAA (0.64) SOAT2SOAT1CNR1L3MBTL1GAA
SCHEMBL9502155 0.87 GAA (0.64) SOAT2SOAT1CNR1L3MBTL1GAA
SCHEMBL4386284 0.87 S1PR3 (0.74) S1PR3SOAT2SOAT1CNR1L3MBTL1
SCHEMBL14441039 0.85 S1PR3 (0.56) S1PR3SOAT1L3MBTL1GAATDP1
SCHEMBL14440895 0.85 S1PR3 (0.56) S1PR3SOAT1L3MBTL1GAATDP1
SCHEMBL14441294 0.84 S1PR3 (0.49) S1PR3L3MBTL1GAATDP1POLB
SCHEMBL14441001 0.83 S1PR3 (0.54) S1PR3SOAT1L3MBTL1GAATDP1
SCHEMBL5461336 0.82 S1PR3 (0.53) S1PR3L3MBTL1GAATDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185176-A1 Heparanase inhibitors and uses thereof INSIGHT BIOHARMACEUTICALS LTD. (IL) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185176-A1 Heparanase inhibitors and uses thereof HPSE, ENGASE, HEXA S1PR3 1318/4885SOAT2 4339/4885SOAT1 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.